☆ 4.7 Article

Bleeding and Thrombotic Complications in Patients With Cirrhosis: A State-of-the-Art Appraisal

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Hematology

Step up to the platelet: Role of platelets in inflammation and infection

Agostina Carestia et al.

Summary: Platelets play a crucial role in immunity and coagulation, able to detect, interact with, and kill pathogens. They induce the formation of microthrombi to prevent pathogen spread and facilitate clearance in the process of immunothrombosis.

THROMBOSIS RESEARCH (2023)

Add to Collection

Article Gastroenterology & Hepatology

Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis

Antonio Guerrero et al.

Summary: This study used an individual patient data meta-analysis to demonstrate the safety and efficacy of anticoagulation in the recanalization of portal vein thrombosis in patients with cirrhosis. Anticoagulation reduces all-cause mortality, but at the expense of increasing non-portal hypertension-related bleeding.

JOURNAL OF HEPATOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD

Bernhard Scheiner et al.

Summary: FVIII/PC ratio predicts the risk of hepatic decompensation/death and ACLF, independently of established prognostic indicators. However, it does not reflect coagulation and is unrelated to thrombosis.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Baveno VII - Renewing consensus in portal hypertension

Roberto de Franchis et al.

Summary: The Baveno VII workshop focused on personalized care for portal hypertension in patients with compensated cirrhosis or cACLD, discussing various aspects including diagnosis, treatment, and prevention measures in 9 main topics, resulting in a series of consensus recommendations.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Article Hematology

Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH

Lara N. Roberts et al.

Summary: Prolonged prothrombin time and thrombocytopenia are common in patients with cirrhosis, but they do not necessarily reflect the overall hemostatic balance or bleeding risk in the periprocedural setting. It is important to carefully evaluate bleeding risk and manage hemostatic abnormalities in these patients during procedures.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates

Annabel Blasi et al.

Summary: The study found that patients with AD and ACLF had higher thrombin generation but lower levels of prothrombin, fibrinogen, and factor XIII compared to healthy controls. Fibrinogen concentrate improved clot quality, while prothrombin complex concentrate increased clot resistance. Further research is needed to determine the clinical benefits of coagulation factor concentrates in preventing or treating bleeding in liver disease patients.

LIVER INTERNATIONAL (2022)

Add to Collection

Article Hematology

Viscoelastometric versus standard coagulation tests to guide periprocedural transfusion in adults with cirrhosis: A meta-analysis of randomized controlled trials

Nuanrat Tangcheewinsirikul et al.

Summary: Compared with conventional SCT-guided transfusion, VET-guided strategy decreases periprocedural plasma and platelet transfusions and transfusion-related adverse events (TRAEs), without increasing hemorrhagic complications, length of stay (LOS) or mortality in cirrhosis.

VOX SANGUINIS (2022)

Add to Collection

Review Gastroenterology & Hepatology

Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis

Jin Hean Koh et al.

Summary: This study aimed to compare the efficacy and safety of DOAC versus VKA in treating non-tumoral PVT in cirrhotic patients. The results showed that DOAC were associated with higher PVT recanalization rate, but had similar bleeding risk compared to VKA.

DIGESTIVE AND LIVER DISEASE (2022)

Add to Collection

Review Gastroenterology & Hepatology

Haemostatic alterations and management of haemostasis in patients with cirrhosis

Ton Lisman et al.

Summary: Patients with cirrhosis experience complex changes in their haemostatic system, but it remains balanced overall. New understanding of clinical management for patients with cirrhosis has emerged, although there is a lack of solid evidence from well-designed clinical studies. The paper outlines recent advances in bleeding and thrombotic complications in patients with cirrhosis.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis

Erica Villa et al.

Summary: This article discusses the challenging issues of bleeding and thrombosis prevention and management in patients with cirrhosis, providing practical guidance. Some recommendations in this document are based on the panel's view that certain commonly used interventions are not useful.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Article Hematology

Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites

Johannes Thaler et al.

Summary: This study investigated the coagulation system in ascites of patients with cirrhosis and found that ascitic fluid was procoagulant with high extracellular vesicle-associated tissue factor activity. Fibrinolytic enzymes were activated in ascitic fluid, potentially re-entering the systemic circulation and inducing systemic fibrinolysis. Plasma D-dimer levels were independently linked to ascites severity in a separate cohort of patients.

THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Hematology

Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis

Matteo Candeloro et al.

Summary: This study conducted an individual-patient meta-analysis to evaluate the effectiveness and safety of anticoagulation for splanchnic vein thrombosis (SVT). The results showed that anticoagulant treatment is associated with a reduced risk of recurrent VTE and major bleeding in SVT patients.

BLOOD ADVANCES (2022)

Add to Collection

Article Gastroenterology & Hepatology

The Incidence of Venous Thromboembolism and Practice of Deep Venous Thrombosis Prophylaxis Among Hospitalized Cirrhotic Patients

Mira Alsheikh et al.

Summary: The use of pharmacological VTE prophylaxis did not show a statistically significant reduction in the risk of VTE in cirrhotic patients. Low albumin appears to be a predictor for developing VTE. Cirrhotic patients not receiving pharmacological VTE prophylaxis have a significantly increased risk of bleeding.

GASTROENTEROLOGY RESEARCH (2022)

Add to Collection

Review Medicine, General & Internal

Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis

Jiahui Pan et al.

Summary: This study reviewed the prevalence and incidence of portal vein thrombosis (PVT) in patients with liver cirrhosis. The results showed that approximately one seventh of cirrhotic patients have PVT, and one tenth will develop PVT. Factors associated with the presence/occurrence of PVT include Child-Pugh class, D-dimer level, ascites, and use of non-selective beta-blockers.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)

Add to Collection

Article Hematology

Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH

Lara N. Roberts et al.

Summary: Hospital-associated venous thromboembolism is a significant cause of morbidity and mortality in patients with cirrhosis. The use of thromboprophylaxis in these patients is challenging due to the uncertain balance between thrombosis and bleeding risk. This guidance document provides pragmatic recommendations on VTE prevention for hospitalized patients with cirrhosis, including drug selection and timing.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Hematology

Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures

Julien Bissonnette et al.

Summary: Global hemostasis tests and clinical questionnaires do not improve prediction of liver biopsy-related bleeding, but pain 2 hours after liver biopsy may indicate potential bleeding complications.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Review Hematology

The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis

Zhiqi Zhang et al.

Summary: This study evaluated the efficacy and safety of anticoagulant therapy in patients with cirrhotic PVT. The results indicate that anticoagulant therapy can increase recanalization rate, reduce thrombus extension rate, and does not increase the risk of bleeding. Subgroup analysis showed that VKA, LMWH, and DOACs can increase recanalization rate without increasing bleeding risk. The study also found that DOACs may be more effective than warfarin.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases

Patrick G. Northup et al.

HEPATOLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology

AGA Technical Review on Coagulation in Cirrhosis

Nicolas M. Intagliata et al.

GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis

Robert S. O'Shea et al.

GASTROENTEROLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia

Domenico Alvaro et al.

Summary: Studies suggest that severe thrombocytopenia may predict bleeding risk following invasive procedures such as liver biopsy, dental extractions, percutaneous ablation of liver tumors, and endoscopic polypectomy. Current literature does not provide definitive conclusions on the appropriate target platelet counts to improve bleeding risk in cirrhotic patients undergoing invasive procedures, and there is huge variability in the use of prophylactic platelet transfusions.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Review Hematology

Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis

Emanuele Valeriani et al.

Summary: Anticoagulant therapy shows positive effects on vein recanalization and progression, major bleeding, and overall mortality in cirrhotic patients with SVT, but the incidence of recurrent VTE remains substantial.

THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis

Yanying Gao et al.

Summary: This study demonstrated that anticoagulants were effective and safe in treating patients with liver cirrhosis and portal vein thrombosis, as they significantly increased the recanalization rate of PVT and decreased the risks of exacerbation and bleeding associated with portal hypertension.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Risk and Outcome of Venous and Arterial Thrombosis in Patients With Cirrhosis: A Danish Nation-wide Cohort Study

Peter Jepsen et al.

Summary: Patients with cirrhosis have an increased risk of venous thromboembolism (VTE) and ischemic stroke (IS), but not acute myocardial infarction (AMI). Decompensation in cirrhosis only increases the risk of AMI. The mortality rate after thrombosis is higher in cirrhosis patients and they are less likely to receive antithrombotic treatment.

HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis

Cheng Han Ng et al.

Summary: The network meta-analysis compared the use of DOACs with traditional anticoagulants in cirrhotic patients with portal venous thrombosis, showing DOACs were superior in achieving complete recanalization compared to LMWH, warfarin, and no treatment. Although not superior in achieving partial recanalization, DOACs had the highest probability according to SUCRA analysis.

HEPATOLOGY INTERNATIONAL (2021)

Add to Collection

Review Gastroenterology & Hepatology

A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?

Shujie Dong et al.

Summary: In cirrhotic patients with PVT, anticoagulation therapy helps increase the rate of PVT recanalization and improve survival, but may also carry higher risks of bleeding compared to no treatment.

HEPATOLOGY INTERNATIONAL (2021)

Add to Collection

Article Multidisciplinary Sciences

Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma

Robin Zenlander et al.

Summary: Plasma markers of NET formation were found to be elevated in liver cirrhosis and hepatocellular carcinoma patients, correlating to the degree of liver dysfunction. Levels of H3Cit-DNA were highest in cirrhosis patients, and Child-Pugh and MELD scores positively correlated with MPO-DNA and H3Cit-DNA levels.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Medicine, General & Internal

Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis

Jian-Bin Zhang et al.

Summary: TIPS is effective for cirrhotic patients with PVT, with high technical success, recanalization, and patency rates. However, encephalopathy remains a concern, and cavernous transformation is a predictor of technical failure. Anticoagulation therapy post-TIPS may not be necessary. Further research on combination therapies is needed.

WORLD JOURNAL OF CLINICAL CASES (2021)

Add to Collection

Article Gastroenterology & Hepatology

CD62P (P-selectin) expression as a platelet activation marker in patients with liver cirrhosis with and without cholestasis

Sara Hegazy et al.

Summary: The study aimed to assess the presence of cholestasis in cirrhotic patients and its relation to bleeding tendency, with platelet CD62P expression evaluated using flow cytometry. Results showed a significant increase in platelets expressing CD62P in all patient groups compared to controls.

CLINICAL AND EXPERIMENTAL HEPATOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis

Le Wang et al.

Summary: This study found that early initiation of anticoagulation can significantly increase portal vein recanalization and improve overall survival in cirrhotic patients. Child-Pugh B and C classes, as well as higher MELD scores, are associated with decreased portal vein recanalization. No predictors specifically related to bleeding events were identified in this meta-analysis.

ADVANCES IN THERAPY (2021)

Add to Collection

Article Gastroenterology & Hepatology

A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures

Sudheer K. Vuyyuru et al.

DIGESTIVE DISEASES AND SCIENCES (2020)

Add to Collection

Article Gastroenterology & Hepatology

ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation

Douglas A. Simonetto et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease

Bernhard Scheiner et al.

LIVER INTERNATIONAL (2020)

Add to Collection

Article Gastroenterology & Hepatology

Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology

James Neuberger et al.

GUT (2020)

Add to Collection

Article Gastroenterology & Hepatology

Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features

Alberto Zanetto et al.

HEPATOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Super-Resolution Microscopy Reveals an Altered Fibrin Network in Cirrhosis: The Key Role of Oxidative Stress in Fibrinogen Structural Modifications

Matteo Becatti et al.

ANTIOXIDANTS (2020)

Add to Collection

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: abnormalities in the International Normalised Ratio (INR) do not correlate with periprocedural bleeding events among patients with cirrhosis

Alexander J. Kovalic et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Add to Collection

Article Medicine, General & Internal

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

Ian Roberts et al.

LANCET (2020)

Add to Collection

Review Pharmacology & Pharmacy

What intervention regimen is most effective prevention for Portal venous system thrombosis after splenectomy in cirrhotics patients with Portal hypertension? Systematic review and network meta-analysis

Hongda Ding et al.

PHARMACOLOGICAL RESEARCH (2020)

Add to Collection

Article Hematology

Thrombin Generation and Cirrhosis: State of the Art and Perspectives

Aurelien Lebreton et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)

Add to Collection

Review Gastroenterology & Hepatology

Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis

Nicolas M. Intagliata et al.

GASTROENTEROLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Acute kidney injury is associated with low factor XIII in decompensated cirrhosis

Nicolas M. Intagliata et al.

DIGESTIVE AND LIVER DISEASE (2019)

Add to Collection

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis

Susana G. Rodrigues et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Add to Collection

Article Hematology

Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase

L. G. Poole et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)

Add to Collection

Review Hematology

Anticoagulation and Transjugular Intrahepatic Portosystemic Shunting for Treatment of Portal Vein Thrombosis in Cirrhosis: A Systematic Review and Meta-Analysis

Jessica P. E. Davis et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2019)

Add to Collection

Review Gastroenterology & Hepatology

Viscoelastic Testing in Liver Disease

Jessica P. E. Davis et al.

ANNALS OF HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis

Vincenzo La Mura et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis

Adelina Hung et al.

LIVER INTERNATIONAL (2018)

Add to Collection

Article Gastroenterology & Hepatology

Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients

Edoardo G. Giannini et al.

ANNALS OF HEPATOLOGY (2018)

Add to Collection

Review Gastroenterology & Hepatology

The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis

Nelson Valentin et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)

Add to Collection

Review Hematology

Direct oral anticoagulants in patients with liver cirrhosis: A systematic review

Evert Willian Hoolwerf et al.

THROMBOSIS RESEARCH (2018)

Add to Collection

Review Gastroenterology & Hepatology

Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis

Lorenzo Loffredo et al.

GASTROENTEROLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Thrombelastography-Guided Blood Product Use Before Invasive Procedures in Cirrhosis With Severe Coagulopathy: A Randomized, Controlled Trial

Lesley De Pietri et al.

HEPATOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation

N. M. Intagliata et al.

DIGESTIVE DISEASES AND SCIENCES (2016)

Add to Collection

Article Gastroenterology & Hepatology

Coagulation Parameters and Major Bleeding in Critically Ill Patients With Cirrhosis

Andreas Drolz et al.

HEPATOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Causes and Consequences of Portal Vein Thrombosis in 1,243 Patients With Cirrhosis: Results of a Longitudinal Study

Filipe Nery et al.

HEPATOLOGY (2015)

Add to Collection

Article Hematology

Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study

J. Shatzel et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)

Add to Collection

Article Hematology

Risk-assessment and pharmacological prophylaxis of venous thromboembolism in hospitalized patients with chronic liver disease

Hanin Bogari et al.

THROMBOSIS RESEARCH (2014)

Add to Collection

Article Gastroenterology & Hepatology

De novo Portal Vein Thrombosis in Virus-Related Cirrhosis: Predictive Factors and Long-Term Outcomes

Hitoshi Maruyama et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

Add to Collection

Review Hematology

Efficacy and safety of the use of heparin as thromboprophylaxis in patients with liver cirrhosis: A systematic review and meta-analysis

Covadonga Gomez Cuervo et al.

THROMBOSIS RESEARCH (2013)

Add to Collection

Editorial Material Pharmacology & Pharmacy

Pharmacologic prophylaxis against venous thromboembolism in hospitalized patients with cirrhosis and associated coagulopathies

Lindsey Koliscak et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2012)

Add to Collection

Article Gastroenterology & Hepatology

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

Erica Villa et al.

GASTROENTEROLOGY (2012)

Add to Collection

Article Hematology

Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests

D. C. Rijken et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)

Add to Collection

Article Gastroenterology & Hepatology

NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation

Stefania Basili et al.

LIVER INTERNATIONAL (2011)

Add to Collection

Article Gastroenterology & Hepatology

Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study

Harry Wu et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)

Add to Collection

Article Immunology

Thromboelastography-Guided Transfusion Decreases Intraoperative Blood Transfusion During Orthotopic Liver Transplantation: Randomized Clinical Trial

S-C Wang et al.

TRANSPLANTATION PROCEEDINGS (2010)

Add to Collection

Article Gastroenterology & Hepatology

The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end-stage liver disease calculation

Armando Tripodi et al.

HEPATOLOGY (2007)

Add to Collection

Article Gastroenterology & Hepatology

A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology

Laurent Bellest et al.

HEPATOLOGY (2007)

Add to Collection

Article Surgery

Changes in international normalized ratio (INR) and Model for Endstage Liver Disease (MELD) based on selection of clinical laboratory

J. F. Trotter et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2007)

Add to Collection

Article Gastroenterology & Hepatology

Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management

Stephen H. Caldwell et al.

HEPATOLOGY (2006)

Add to Collection

Article Gastroenterology & Hepatology

Thrombin generation in patients with cirrhosis: The role of platelets

Armando Tripodi et al.

HEPATOLOGY (2006)

Add to Collection

Article Gastroenterology & Hepatology

Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism

PG Northup et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)

Add to Collection

Article Gastroenterology & Hepatology

Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity

T Lisman et al.

HEPATOLOGY (2006)

Add to Collection

Article Gastroenterology & Hepatology

Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests

A Tripodi et al.

HEPATOLOGY (2005)

Add to Collection

Article Gastroenterology & Hepatology

Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study

P Montalto et al.

JOURNAL OF HEPATOLOGY (2002)

Add to Collection

Article Hematology

Recombinant coagulation factor VIIa: From the concept to clinical application in hemophilia treatment in 2000

U Hedner

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.